UK-EDI: UK Early Detection Initiative for Pancreatic Cancer.

UK-EDI is a research programme funded by Cancer Research UK which will explore the link between new-onset diabetes and pancreatic cancer with the aim of finding ways to diagnose pancreatic cancer earlier.

Most cases of type 2 diabetes are due to lifestyle or genetic factors. However, in approximately 1 in 100 people, a new diagnosis of type 2 diabetes could be an early warning sign of pancreatic cancer.

Through this research we hope to develop a diagnostic test for use in individuals newly diagnosed with diabetes which will identify those most at risk of pancreatic cancer, allowing them to be screened.

The aim of UK-EDI is to detect pancreatic cancer earlier.

UK-EDI consists of seven work packages that contribute to the overall aim of the programme.

UK-EDI is hosted by the University of Liverpool in collaboration with the Liverpool Clinical Trials Centre (LCTC), Liverpool GCP labs, Liverpool ECMC and the University of Strathclyde.

Contact us
Liverpool Clinical Trials Centre
University of Liverpool
1st Floor Block C Waterhouse building
L69 3GL
+44(0)151 794 8852
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.